XBiotech(XBIT)
AUSTIN, TX
BiotechnologyFocus: Antibody Therapy
XBiotech is a life sciences company focused on Antibody Therapy.
ImmunologyOncology
Funding Stage
PUBLIC
Employees
5000+
Total Funding
$2.5M
Open Jobs
1
Pipeline & Clinical Trials
NatrunixTM
PharmacokineticsClinical Trials (1)
NCT05099510Natrunix Safety PK Study in Healthy Volunteers
Phase 1Hutrukin
PharmacokineticsClinical Trials (1)
NCT05098080Hutrukin to Analyze Safety and PK in Healthy Volunteers
Phase 1Phase 1/2
Clinical Trials (1)
NCT02357966Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
Phase 1/2XB2001 or Placebo
Pancreatic CancerClinical Trials (1)
NCT04825288XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
Phase 1/2Natrunix 400 mg
Rheumatoid ArthritisClinical Trials (1)
NCT06590090Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment
Phase 2Natrunix
Rheumatoid ArthritisClinical Trials (1)
NCT05363891Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
Phase 2Natrunix
Axial SpondyloarthritisClinical Trials (1)
NCT06526377Natrunix in HLA-B27 Positive Subjects With Axial Spondyloarthritis
Phase 2Natrunix with MTX placebo
Rheumatoid ArthritisClinical Trials (1)
NCT05363917Natrunix Versus Methotrexate in Rheumatoid Arthritis
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 8 clinical trials
SEC Filings: 2 available
Open Roles: 1 active job